Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32). (Q43294223)
Jump to navigation
Jump to search
scientific article published in April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32). |
scientific article published in April 2010 |
Statements
1 reference
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32). (English)
1 reference
Jason T Olin
1 reference
Vinod Bhatnagar
1 reference
Patricio Reyes
1 reference
Barbara Koumaras
1 reference
Xiangyi Meng
1 reference
Stephen Brannan
1 reference
1 April 2010
1 reference
1 reference
1 reference
Identifiers
1 reference